DMJ-I-228

CAS No. 1374035-59-2

DMJ-I-228 ( +)-DMJ-I-228 )

Catalog No. M11542 CAS No. 1374035-59-2

A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    DMJ-I-228
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
  • Description
    A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.
  • Synonyms
    +)-DMJ-I-228
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1374035-59-2
  • Formula Weight
    435.84
  • Molecular Formula
    C19H19ClFN5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC1=CC=C(Cl)C(F)=C1)C(N[C@@H]2[C@@H](NC(N)=N)CC3=C2C=CC=C3)=O.O=CO
  • Chemical Name
    N1-(4-chloro-3-fluorophenyl)-N2-((1S,2S)-2-guanidino-2,3-dihydro-1H-inden-1-yl)oxalamide formate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Madani N, et al. Structure. 2008 Nov 12; 16(11):1689-701.
2. Richard J, et al. Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94.
3. LaLonde JM, et al. J Med Chem. 2012 May 10;55(9):4382-96.
molnova catalog
related products
  • Doravirine

    Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.

  • Ginsenoside Z-R1

    Zingibroside R1 has anti-HIV-1 activity.

  • Diphyllin

    Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.